Viewing nowJanical Tablet (Risedronate Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Samnam Pharmaceutical Co., Ltd.

MFDS item code 201003164 · Approved 2010.04.29 · Insurance code 653701880
Treatment and prevention of osteoporosis in postmenopausal women
This medication is used for the treatment and prevention of osteoporosis in postmenopausal women.
1. Adults : Administer 150 mg of risedronate sodium orally once monthly. 2. Older adults : No dosage adjustment is necessary in older adults (over 60 years) because the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or more. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. ○ Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before the first food or beverage other than water of the day. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled dosing day, follow these instructions. - If the next scheduled dosing day is 7 days or more away, take 1 tablet the morning after remembering. Resume taking the next dose on the originally scheduled dosing day. Do not take more than 1 tablet of this medicine within 7 days. - If the next scheduled dosing day is within 7 days, wait until the originally scheduled dosing day and then take 1 tablet of this medicine.
3. Children : The safety and efficacy of this medicine in children under 18 years of age have not been established.
This medication may cause gastrointestinal irritation; therefore, patients with diseases of the esophagus or stomach should take special care when using it. After taking the medication, it should be taken with a sufficient amount of water, and the patient should not lie down for at least 30 minutes. If any abnormal symptoms occur in the esophagus, the medication should be stopped immediately and the patient should consult a doctor. This medication should not be used in patients with certain esophageal diseases, hypocalcemia, severe renal impairment, or in women who are pregnant or breastfeeding. Additionally, caution is advised for patients with lactose intolerance. This medication may hinder the absorption of other medications containing calcium, magnesium, or iron, so an interval should be taken between dosing. Rarely, serious side effects such as bone or muscle pain and jaw osteonecrosis may occur with long-term use; any symptoms should be discussed with healthcare professionals. Adequate intake of calcium and vitamin D, along with weight-bearing exercises and maintenance of a healthy lifestyle, will aid in treatment. Women who are pregnant or breastfeeding should avoid taking this medication, and its safety and effectiveness have not been established for children under the age of 18. In case of overdose, symptoms of hypocalcemia may appear, so the healthcare provider should be notified immediately for appropriate treatment. This medication should be stored out of the reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that prevents air from entering, and it is recommended to keep it at room temperature between 1°C and 30°C. Storing it this way will help maintain the effectiveness of the medication over time.
Bright blue oval film-coated tablet
1 tablet (1 tablet/PTP packaging X 1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Samnam Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.